Literature DB >> 15306604

Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance?

A P Cuthbert, S A Fisher, C M Lewis, C G Mathew, J Sanderson, A Forbes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15306604      PMCID： PMC1774173          DOI： 10.1136/gut.2003.032946

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Use of unlinked genetic markers to detect population stratification in association studies.

Authors:  J K Pritchard; N A Rosenberg
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

Authors:  Muddassar M Mirza; Sheila A Fisher; Kathy King; Andrew P Cuthbert; Jochen Hampe; Jeremy Sanderson; John Mansfield; Peter Donaldson; Andrew J S Macpherson; Alastair Forbes; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Am J Hum Genet       Date:  2003-03-03       Impact factor: 11.025

Review 3.  Population stratification and spurious allelic association.

Authors:  Lon R Cardon; Lyle J Palmer
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

4.  Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error?

Authors:  Jianfeng Xu; Aubrey Turner; Joy Little; Eugene R Bleecker; Deborah A Meyers
Journal:  Hum Genet       Date:  2002-12       Impact factor: 4.132

5.  Control of confounding of genetic associations in stratified populations.

Authors:  Clive J Hoggart; Eteban J Parra; Mark D Shriver; Carolina Bonilla; Rick A Kittles; David G Clayton; Paul M McKeigue
Journal:  Am J Hum Genet       Date:  2003-06       Impact factor: 11.025

6.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

7.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

9.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682
  9 in total
  2 in total

1.  Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India.

Authors:  Ujjala Ghoshal; Sushil Kumar; Virendra Jaiswal; Shweta Tripathi; Balraj Mittal; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2013-04-12

Review 2.  Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.

Authors:  Isabelle Cleynen; Peter Jüni; Geertruida E Bekkering; Eveline Nüesch; Camila T Mendes; Stefanie Schmied; Stefan Wyder; Eliane Kellen; Peter M Villiger; Paul Rutgeerts; Séverine Vermeire; Daniel Lottaz
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.